FRANKLIN LAKES, N.J., Oct. 9, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the enrollment of the first patient in ...
| Future Market Insights NEWARK, Del., April 13, 2026 /PRNewswire/ -- According to the latest market analysis by Future Market Insights, the global central venous catheter market is witnessing ...
WEST LAFAYETTE, Ind. — Emboa Medical Inc., a medical device startup, has mimicked a snake’s evolutionary advantage to improve the retrieval of blood clots that cause stroke. The company has created a ...
3don MSN
Deep inside the heart: the innovative catheter designed to revolutionise the treatment of arrhythmia
Around 10% of Europeans aged 60 and above are reported to suffer from heart arrhythmia. “Clinical perception of the condition ...
U.S. IDE Enrollment follows groundbreaking 96% procedural success at 12 months in European feasibility studyHAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of ...
Demonstrating that the best solution is not always a multistage approach, a new trial showed catheter ablation is superior to a combination of antiarrhythmic drugs and lifestyle changes — weight loss, ...
Evaluating the effectiveness of treatment cost calculation tool in improving patients' understanding of drug costs in advanced breast cancer: A multicenter, randomized controlled trial. PIV ...
NEW ORLEANS, LA—The diabetes drug metformin can reduce recurrence of atrial arrhythmia for patients with overweight and obesity undergoing catheter ablation even if they’re not diabetic, results from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results